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Abstract The kinetics of the interaction of lipopolysaccharide
(LPS), lipopolysaccharide binding protein (LBP) and CD14 was
studied using surface plasmon resonance. The association and
dissociation rate constants for the binding of LPS and rsCD14
were 2.9U104 M31 s31 and 0.07 s31 respectively, yielding a
binding constant of 4.2U105 M31. Signi¢cantly, the presence of
LBP increased not only the association rate but also the asso-
ciation constant for the interaction between LPS and CD14 by
three orders of magnitude. Our experimental results suggest
that LBP interacts with LPS and CD14 to form a stable tri-
molecular complex that has signi¢cant functional implications
as it allows monocytes to detect the presence of LPS at a con-
centration as low as 10 pg/ml or 2 pM, and to respond by
secreting interleukin-6. Thus, LBP is not merely transferring
LPS to CD14 but it forms an integral part of the LPS^
rLBP^rsCD14 complex.
2 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The importance of innate immunity in recognizing micro-
bial pathogens and mounting a response against them is now
widely recognized. Bacterial endotoxin, lipopolysaccharide
(LPS) of gram-negative bacteria, has been a model in the
study of the innate immunity [1,2]. LPS plays a pivotal role
in the septic shock syndrome in humans owing to its profound
e¡ects on the innate immune system. Septic shock is charac-
terized by fever, hypoxia, hypoglycemia, acidosis, thrombocy-
topenia, hypotension, which often leads to multiple organ fail-
ure/dysfunction syndrome [3]. There have been various studies
into the molecular basis of the septic shock syndrome that
clearly demonstrate that LPS itself is not toxic. It is the ability
of LPS to interact with and stimulate a variety of target cells
that subsequently produce the potentially lethal mediators of
septic shock [4]. The proin£ammatory cytokines, including
tumor necrosis factor (TNF)-K [5], interleukin (IL)-1L, IL-6
[6], IL-8 and IL-12 and interferon-Q, play a critical role in the
in£ammatory response [7].
CD14 and LPS binding protein (LBP) are known to play
important roles in the pathway leading to the endotoxic shock
caused by LPS. Blockage of LBP with antibodies or experi-
ments using CD14 knockout mice resulted in prevention of
LPS-induced shock [8,9]. CD14 is a 55-kDa glycoprotein that
is present in a soluble form (sCD14) in blood and in a glyco-
sylphosphatidyl-anchored, membrane-bound form (mCD14)
on the surface of monocytes, macrophages and polymorpho-
nuclear leukocytes (PMN). LBP, a 60-kDa serum acute phase
protein, has been described as a lipid transfer molecule that
catalyzes movement of phospholipids, in particular LPS
monomers, from LPS aggregates to lipoproteins or to CD14
[10].
It has been shown earlier that LPS can directly bind to cells
transfected with mCD14 [11], to monocytes [12] and to PMN
[12] as well as to sCD14 [12^15]. LPS^sCD14 complexes acti-
vate endothelial or epithelial cells and U373 astrocytoma cells,
which do not express mCD14 [12,14,16], and also enhance
LPS stimulation of monocytes [14], macrophages [15], or
PMN [13], even though these three cell types express
mCD14. In the latter instances there seems to be a cooperative
action of sCD14 and mCD14 whereby sCD14 delivers LPS to
mCD14 [15]. LBP on its own is unable to trigger an LPS
response [12]. However, LBP can catalytically transfer mono-
meric LPS from LPS aggregates onto mCD14 or sCD14 mol-
ecules and thus greatly enhance CD14-mediated responses to
LPS [10,13,17,18]. Activation of cells via sCD14 occurs by
binding of sCD14 to a yet unde¢ned signal molecule, which
is found on monocytes, endothelial cells and some epithelial
cells [12]. Whether LPS is already bound to sCD14 or sub-
sequently binds to mCD14, CD14 is required to bring LPS
into close proximity to the toll-like receptor 4 (TLR4) [19] and
to transfer it to the TLR4^MD-2 complexes present at the cell
surface [20]. Although earlier studies give an insight into the
interaction between the major players of endotoxic shock,
there is still a need to quantitatively ascertain the parameters
that govern these interactions. In particular how LBP in-
creases the cellular responses of LPS has so far remained
elusive.
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In this study, using surface plasmon resonance (SPR) we
demonstrate that while the a⁄nity of LPS for recombinant
sCD14 (rsCD14) is intrinsically low, it increases by three or-
ders of magnitude when present in complex with rLBP. The
increase in a⁄nity is largely related to an increase in the
association rate constant indicating that LBP^LPS complex
presents the determinants optimally for the recognition of
CD14. The functional consequences of these results are com-
plemented by analysis of IL-6 secretion by monocytes cultured
under the in£uence of LPS in the presence or absence of
rsCD14 and/or rLBP.
2. Materials and methods
2.1. Media and reagents
Monocyte cultures were established in RPMI 1640 medium (Sigma,
St. Louis, MO, USA) supplemented with 20 mM L-glutamine (Life
Technologies, Paisley, UK) and 1% human serum depleted of sCD14
and LBP (ELISA tests detected 10 ng/ml sCD14 and 2 ng/ml LBP
after depletion) (Biometec, Greifswald, Germany). Recombinant hu-
man endotoxin-free sCD14 and rLBP were obtained from Biometec.
LPS from Escherichia coli strain O55:B5 (Sigma) was repuri¢ed as
described earlier [21].
2.2. SPR analysis
LPS samples were prepared and quanti¢ed using the endotoxin
from Endosafe1, as a standard, by the Limulus amebocyte lysate
assay in pyrogen-free water according to the method of Yin et al.
[22], prior to all the assays. Biospeci¢c interaction analysis was per-
formed using a BIAcore 2000 biosensor system (Amersham Pharma-
cia Biotech, Uppsala, Sweden). For the analysis of rLBP^LPS inter-
action, LBP was covalently immobilized on a certi¢ed grade CM5
sensor chip (carboxymethylated) at a concentration of 40 Wg/ml in
10 mM sodium acetate bu¡er, pH 4.8, using the amine coupling kit
supplied by the manufacturer. Nearly 1500 resonance units (RU) of
the protein were immobilized under these conditions, where 1 RU
corresponds to immobilized protein concentration of V1 pg/mm2.
The unreacted moieties on the surface were blocked with ethanol-
amine. All measurements were carried out in 10 mM HEPES, pH
7.4, 150 mM NaCl, 3.4 mM EDTA. LPS was £owed over these
surfaces at concentrations of 6, 8, 12, 20, 25, 35 nM at 25‡C, in
HEPES bu¡er at a £ow rate of 10 Wl/min in order to determine the
association rate constant. For the determination of dissociation rate
constant, the same bu¡er was passed at a £ow rate of 10 Wl/min. The
surfaces were regenerated by a 10-s pulse of 10 mM glycine^HCl (pH
4.2) £owing at 50 Wl/min. These surfaces have greater than 90% re-
producibility if used in quick succession, i.e. within 24 h.
Recombinant sCD14 was also covalently immobilized on a certi¢ed
grade CM5 sensor chip using the amine coupling kit at a concentra-
tion of 40 Wg/ml. Nearly 1500 RUs of the protein were immobilized
under these conditions. LPS (40, 55, 75, 100 nM) was passed over the
immobilized rsCD14 to study the interaction of LPS and rsCD14.
Also, LPS (200 nM) was mixed with increasing concentrations of
rLBP (5, 10, 15, 25, 80, 140 nM) and passed over rsCD14 in order
to study the interaction of LPS^rLBP complex with rsCD14. For
the determination of association rate constant (k1), LPS or the
LPS^rLBP complex, as the case may be, was used at a £ow rate of
10 Wl/min, in HEPES bu¡er. Dissociation rate constant (k31) was
evaluated subsequently by passing the same bu¡er at a £ow rate of
10 Wl/min. Also, as a control, rLBP alone was passed over immobi-
lized rsCD14 and the data so obtained were subtracted from those
obtained upon passing the complex of rLBP and LPS over immobi-
lized rsCD14.
One of the surfaces was activated and blocked by ethanolamine.
This was used as a control to negate the e¡ect of any interaction
between LPS, rLBP or rsCD14 with the ethanolamine used during
the immobilization procedure. In all the cases there was no detectable
increase in RUs upon passage of LPS, rLBP or rsCD14 over the
control surface.
2.3. Data analysis
Rate constants k1 and k31 were obtained by ¢tting the primary
sensorgram data using the BIA evaluation 3.0 software. The dissoci-
ation rate constant is derived using:
Rt ¼ Rt0 e3k31ðt3t0Þ ð1Þ
where Rt0 is the amplitude of the initial response, and k31 is the
dissociation rate constant. The association rate constant k1 can be
derived from the measured k31 values, using:
Rt ¼ Rmax ½13e3ðk1Cþk31Þ ðt3t0Þ ð2Þ
where Rt is the response at time t, Rmax is the maximum response, C is
the concentration of the analyte in the solution, and k1 and k31 are
the association and dissociation rate constants, respectively. The ratio
of k1 and k31 yields the value of association constant Ka (k1/k31). The
parameters obtained from the binding interaction of the ligands with
the protein on the surface of the chip were also plotted as per Scatch-
ard analysis [23].
2.4. Monocyte culture and analysis of conditioned medium
Monocytes, obtained from normal healthy volunteers with their
informed consent, were isolated by continuous £ow centrifugation
leukapheresis and counter£ow centrifugation elutriation and cultured
as in [24]. This technique yields monocytes with a 95^98% degree of
purity, as judged by £ow cytometry using the surface marker CD14.
Monocytes were maintained in a humidi¢ed atmosphere, at 37‡C, in
the presence of 5% CO2, in RPMI 1640 supplemented with 20 mM
L-glutamine and 1% human serum, depleted of sCD14 and LBP and
in the presence or absence of either LPS (5, 15, 30 or 60 pg/ml),
and/or 2 Wg/ml rsCD14, and/or 1 Wg/ml rLBP. The ¢nal concentra-
tions of CD14 and LBP as present in each assay system were less than
0.1 ng/ml and 0.05 ng/ml which was 0.005% of the extraneously added
CD14 and LBP. Also, rsCD14 and LBP used in the assays were tested
for endotoxin by Biometec and the endotoxin content was less than
0.1 ng/ml. In addition to this we also had the products tested by the
endotoxin research laboratories of the Octapharma pharmaceutical
company, which also could not detect endotoxin contamination.
Monocytes (2U106 cells/ml/well) were cultured in 24-well plates
(Nunc, Roskilde, Denmark). After incubation of the monocytes
with rLBP, LPS or rsCD14 for 24 h, culture supernatants were har-
vested and IL-6 secretion was determined by sandwich ELISA accord-
ing to the manufacturer’s instructions (Immunotech, Marseille,
France).
3. Results and discussion
SPR is a rapid method for evaluating the elementary steps
of a reaction between a macromolecule and its complementary
ligand as well as the a⁄nities involved therein, as proven by
the wealth of data in the literature [25^27]. Real-time biomo-
lecular interaction analysis (BIA) relies exclusively on the
mass change, without the need for labeling any of the inter-
actants, which can sometimes alter the nature of the reaction.
Also, this technique provides data for both the association
and dissociation phases of a reaction in a single experimental
run.
3.1. Analysis of the interaction of rLBP and LPS
The interaction of rLBP and LPS yielded k1, k31 and Ka
values of 1.23U106 M31 s31, 4.26U1033 s31 and 2.88U108
M31, respectively (Fig. 1A). The equilibrium binding constant
(Keq) calculated from the Scatchard plot was 1.4U108 M31
(Fig. 1B). These values are in accordance with earlier studies
utilizing indirect approaches such as ELISA and competitive
binding reactions via £uorescently labeled polymyxin B, an
extensively investigated ligand for LPS, reporting values of
Kd for LPS^LBP interaction in the nanomolar range (i.e.
Kb = 1.25U108 M31) at 20‡C [1]. Ulevitch et al. report a value
of 2.85U108 M31 for the same interaction [18].
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3.2. Analysis of the interaction of LPS and LPS^rLBP
complex with immobilized rsCD14
The association and dissociation rate constants for the
binding of LPS to immobilized rsCD14 were, respectively,
2.9U104 M31 s31 and 0.07 s31 yielding a Ka value of
4.2U105 M31 (Fig. 2A). The equilibrium binding constant
was calculated as 9.8U105 M31 (Fig. 2B). Next, a constant
amount of LPS was incubated with increasing concentrations
of rLBP and the complex so formed was passed over immo-
bilized rsCD14. The amount of rLBP complexed under these
conditions was calculated and used for the kinetic and Scatch-
ard analysis of the data (Fig. 3). The data for the binding of
LPS^rLBP complex were obtained after subtracting the re-
sponse observed upon passing equivalent amounts of free
LPS and free LBP over immobilized rsCD14. k1 for the inter-
action of LPS^rLBP complex with immobilized rsCD14 was
much more rapid than the one observed for the binding of
LPS to rLBP and LPS to rsCD14. The association rate con-
stant for the interaction of rLBP^LPS complex to rsCD14 was
calculated as 1.3U107 M31 s31 whereas the dissociation rate
constant was observed to be 0.06 s31, giving the value of
overall binding constant of 2.16U108 M31. Scatchard analysis
of the SPR data yielded a Keq of 1U108 M31. The binding
constants so obtained clearly demonstrate the role of LBP in
the interaction of LPS to rsCD14.
LPS in complex with LBP binds mCD14, on the surface of
responsive cells such as monocytes and macrophages. How-
ever, it is not yet resolved whether this interaction requires a
trimolecular complex between LPS, LBP and CD14. Indeed,
Hailman et al. [13] were unable to observe, by native polyac-
rylamide gel electrophoresis, a stable complex of rLBP with
rsCD14 and LPS while Gegner et al. [28] have reported that
LPS forms a ternary complex with LBP and mCD14 at the
cell surface.
Our studies demonstrate that LBP perhaps orients LPS in a
manner that favors its recognition by CD14 (Figs. 3 and 4).
The agreement between kinetically determined values of asso-
ciation constants (k1/k31) and those determined by Scatchard
analysis of the SPR data suggests that the association and
dissociation reactions are monoexponential in nature and de-
scribe faithfully the energetics of the system. The observation
of a monoexponential phase for the interaction between LPS^
Fig. 1. A: Overlay plot of sensorgrams depicting the interaction of
LPS with LBP. LBP was immobilized on CM5 sensor chip and LPS
at concentrations of 6, 8, 12, 20, 25, 35 nM, from bottom to top,
dissolved in 10 mM HEPES bu¡er, containing 150 mM NaCl, 3.4
mM EDTA, pH 7.4, was passed at a £ow rate of 10 Wl/min. The
dissociation was studied subsequently by passing the same bu¡er at
a £ow rate of 10 Wl/min. The surfaces were regenerated by a 10-s
pulse of 10 mM glycine^HCl (pH 4.2) £owing at 50 Wl/min. B:
Scatchard plot analysis of the sensorgram data yielding a Keq of
1.4U108 M31.
Fig. 2. A: Interaction of rCD14 with LPS. RsCD14 was immobi-
lized on CM5 sensor chip using the amine coupling kit and the sur-
face blocked by using ethanolamine. LPS was passed over this at
concentrations of 40, 55, 75, 100 nM at a £ow rate of 10 Wl/min. B:
Scatchard plot analysis of the binding data with a Keq of 9.8U105
M31.
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rLBP complex and rsCD14, together with dramatically in-
creased RUs for the reaction between the complex of LBP^
LPS and rsCD14 as compared to the binding of LPS alone,
suggests that LBP is not merely transferring LPS to the latter
but associating itself, as well as forming an integral part of an
LPS^LBP^sCD14 trimolecular complex. Also, the large in-
crease in the value of Ka for the interaction of rsCD14 with
LPS in the presence of LBP occurs mostly due to three orders
of magnitude increase in the association rate constant.
3.3. Monocytes secrete IL-6 when cultured in the presence of
minute amounts of LPS in the presence of rsCD14 and/or
rLBP
TLR family members expressed on monocytes, B cells, adi-
pocytes, intestinal epithelial and dermal endothelial cells [29]
recognize LPS complexed to CD14 and transduce the signal
for NF-UB to the nucleus. This in turn causes the release of
cytokines and cellular mediators to elicit an in£ammatory
response intended to eliminate the infection. In this context,
we studied the release of IL-6 from CD14þ monocytes as an
indicator of their activation by LPS in the presence or absence
of LBP and/or sCD14.
Stimulation of monocytes from di¡erent donors gave results
which were qualitatively similar, considering the magnitude of
increase of IL-6 secretion as a function of stimulating condi-
tions. However, quantitative di¡erences were observed be-
tween donors. Two representative examples are shown in
Fig. 4. Thus, incubation of monocytes in 1% human serum
depleted of sCD14 and LBP with minute amounts of LPS (5^
60 pg/ml) entails barely detectable IL-6 secretion. LBP has a
concentration-dependent dual role in the pathogenesis of
Gram-negative sepsis : low concentrations of LBP enhance
the LPS-induced activation of mononuclear cells, whereas
the acute phase rise in LBP concentrations inhibits LPS-in-
duced cellular stimulation [30]. Thus, we used low concentra-
tions of rLBP in the experiments. The addition of 1 Wg/ml
rLBP induced secretion of IL-6 only when LPS was also
Fig. 3. A: Interaction of LBP^LPS complex with immobilized
rCD14. LPS (200 nM) was mixed with increasing concentrations (5,
10, 15, 25, 80, 140 nM; second sensorgram from bottom to top) of
rLBP and passed over immobilized rsCD14 at a £ow rate of 10 Wl/
min. rLBP alone (¢rst sensorgram from the bottom) when passed
over immobilized rsCD14 showed no evidence of interaction even
when a ¢ve-fold higher concentration was passed as compared to
the experiments with the highest concentrations of the complex (viz.
rLBP^LPS complex). B: Scatchard plot analysis of the same sensor-
gram with a Keq of 1U108 M31.
Fig. 4. Secretion of IL-6 by monocytes. Histograms A and B show
the e¡ect of various concentrations of LPS (0, 5, 15, 30, 60 pg/ml)
on the secretion of IL-6 by freshly elutriated monocytes obtained
from two di¡erent donors and cultured in the presence of 1% hu-
man serum depleted of sCD14 and LBP. The consequences of the
presence of 1 Wg/ml rLBP or 2 Wg/ml rsCD14, or both of these mol-
ecules in the culture medium are shown. Note in B that 60 pg/ml of
LPS induced secretion of 72 pg/ml of IL-6, while the same amount
of LPS in the presence of rLBP and rsCD14 induced secretion of
25 052 pg/ml of IL-6.
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present. Addition of 2 Wg/ml rsCD14 to the monocytes led to
the secretion of 174 pg/ml of IL-6, in the absence of any
added LPS, an observation that can be correlated with the
report by Landmann et al. [31] who showed that under se-
rum-free conditions, endotoxin-free rsCD14 induced mono-
cytes to secrete TNF-K. However, under physiological condi-
tions this activation is precluded by a platelet-derived possibly
lipidic inhibitor. The secretion of IL-6 was increased by more
than ¢ve-fold upon incubation of the monocytes with 2 Wg/ml
rsCD14 and 60 pg/ml of LPS. Finally, the addition of both
1 Wg/ml rLBP and 2 Wg/ml rsCD14 in the presence of 60 pg/ml
LPS led to secretion of 2836 pg/ml of IL-6 and an increase in
the sensitivity of the monocytes to LPS. Secretion of IL-6 is
observed for even very low concentrations of LPS (5 pg/ml). It
has been shown earlier that addition of immunopuri¢ed
sCD14, in the apparent absence of LBP, enabled responses
to LPS by cells that do not express mCD14, like the astrocy-
toma line U373 or endothelial cells (for levels of LPS more
than 1 Wg/ml and less than 10 ng/ml, respectively) [12,13].
Likewise, it has been shown that rsCD14 substituted for se-
rum to enable LPS stimulation of paroxysmal nocturnal he-
moglobinuria mCD14-de¢cient peripheral blood mononuclear
cells, but also LPS stimulation of mCD14-replete normal
monocytes. Indeed, mCD14-bearing monocytes, incubated
with low concentrations of LPS (10 ng/ml), in serum-free con-
ditions, i.e. in the absence of both sCD14 and LBP, appear to
be extremely sensitive to small concentrations of rsCD14 [14].
Likewise, the stimulation of CD14þ PMN by LPS is dramat-
ically enhanced by rsCD14 even in the absence of LBP [13]. If
in our system the addition of rLBP alone failed to induce IL-6
secretion from monocytes, its addition in the presence of min-
ute amounts of LPS clearly induced such secretion. The ability
of rLBP to trigger a response in the presence of pg quantities
of LPS was previously reported by Lee et al. [11], in a study of
the conditions of IgM expression at the surface of a murine
pre-B cell line transfected by mCD14. However, the monocyte
response to LPS in the presence of rLBP is striking when the
latter molecule is added concomitantly with rsCD14. Under
these conditions, one observes IL-6 secretion at LPS levels as
low as 5 pg/ml (corresponding to 0.045 EU/ml). Thus, our
results show that the increase in the a⁄nity of LPS for
rsCD14, in the presence of rLBP, reduces the amount of
LPS required to trigger IL-6 secretion by monocytes. They
emphasize the high sensitivity of monocytes to tiny amounts
of LPS, when incubated with sCD14 and LBP (Fig. 4).
Finally, it was recently shown that CD14 (in either its mem-
brane or soluble form) is essential for LPS to be brought into
close proximity and transferred to the TLR4^MD-2 com-
plexes present at the cell surface [19,20]. Our functional stud-
ies underline the e⁄ciency of LPS^LBP^sCD14 trimolecular
complexes in this transfer and suggest that minute amounts of
LPS are better delivered by sCD14 than by mCD14 to the
TLR4^MD-2 complex.
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